Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

Hiroshima University

Status: Completed

Conditions: Hyperuricemia

Treatments: Dietary Supplement: 400 mg of chrysanthemum flower oil; Dietary Supplement: 300 mg of chrysanthemum flower oil; Dietary Supplement: 200 mg of chrysanthemum flower oil

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02213562

eki-997

Details and patient eligibility

About

The aim of this study is to investigate the efficacy and dose-dependency of chrysanthemum flower oil in suppressing serum uric acid.

Enrollment: 21 estimated patients

Sex: Male

Ages: 30 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Serum uric acid 6.8-8.9 mg/dL

Exclusion criteria

• Taking anti-hyperuricemic drugs
• History of gouty attack
• Taking drugs or functional food that may affect serum uric acid level
• Hypertention, hyperlipidemia, or diabetes millitus
• Participation in any clinical trial within 90 days of the commencement of the trial
• Renal or hepatic dysfunction
• Heart disease
• History of severe disease and/or major surgery

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

21 participants in 3 patient groups

200 mg CFO

Experimental group

Description:

200 mg of chrysanthemum flower oil

Treatment:

Dietary Supplement: 200 mg of chrysanthemum flower oil

300 mg CFO

Experimental group

Description:

300 mg of chrysanthemum flower oil

Treatment:

Dietary Supplement: 300 mg of chrysanthemum flower oil

400 mg CFO

Experimental group

Description:

400 mg of chrysanthemum flower oil

Treatment:

Dietary Supplement: 400 mg of chrysanthemum flower oil